Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Pediatric Blood & Cancer|September 5, 2017
Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomasChristian Spurny, Sareetha Kailayangiri, Silke Jamitzky, et al.
Cancer Research|September 7, 2007
Gene-engineered varicella-zoster virus reactive CD4+ cytotoxic T cells exert tumor-specific effector functionSilke Landmeier, Bianca Altvater, Sibylle Pscherer, et al.
International Journal of Cancer|May 30, 2009
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic diseasePeter Brinkrolf, Silke Landmeier, Bianca Altvater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2009
2B4 (CD244) signaling by recombinant antigen-specific chimeric receptors costimulates natural killer cell activation to leukemia and neuroblastoma cellsBianca Altvater, Silke Landmeier, Sibylle Pscherer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 21, 2005
Target antigen expression on a professional antigen-presenting cell induces superior proliferative antitumor T-cell responses via chimeric T-cell receptorsClaudia Rossig, Annette Bär, Sibylle Pscherer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Activated human gammadelta T cells as stimulators of specific CD8+ T-cell responses to subdominant Epstein Barr virus epitopes: potential for immunotherapy of cancerSilke Landmeier, Bianca Altvater, Sibylle Pscherer, et al.
Cancer Immunology, Immunotherapy : CII|June 29, 2014
Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individualsBianca Altvater, Sareetha Kailayangiri, Nadine Theimann, et al.
Pageof 4